Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Steven M. Rosenblatt, MD, is a Staff Surgeon in the Department of General Surgery at Cleveland Clinic. He joined Cleveland Clinic as a Clinical Associate in 2000 after completing a fellowship in advanced laparoscopy in the Department of General Surgery. Dr. Rosenblatt also holds staff positions with the Minimally Invasive Surgery Center and the Aging Brain Center, located at the Cleveland Clinic main campus. He is licensed by the State Medical Board of Ohio and board-certified by the American Board of Surgery. His specialty interests include gastrointestinal and laparoscopic hernia surgery.
After earning a bachelor of arts degree in religion from Dartmouth College, Dr. Rosenblatt received his medical degree from the Case Western Reserve University School of Medicine and was named winner of the Hewlett Packard Co. Top Medical Graduate Award.
Dr. Rosenblatt has lectured widely on laparoscopic surgery and related topics at medical conferences across the country and has co-authored many articles that have appeared in leading medical journals, such as Surgical Endoscopy, Neurosurgery and the Journal of the American College of Surgeons. He has been involved in numerous research projects in his field, including assessment of pre- and postoperative symptoms of biliary colic, operative management of obscure gastrointestinal bleeding, laparoscopic splenectomy in the morbidly obese and many more.
His professional memberships include the American College of Surgeons, the Society of American Gastrointestinal and Endoscopic Surgeons, the American Hernia Society, the Central Surgical Association and the International Society for Peritoneal Dialysis.
biliary system and splenectomy, gastrointestinal surgery, laparoscopic placement of CAPD catheters, laparoscopic surgery of hernias, major abdominal wall reconstruction
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 1/4/2013, Dr. Rosenblatt has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.